Profile
Jeffrey M.
Johnston worked as Vice President-Clinical Research at Triangle Pharmaceuticals, Inc. and as Chief Medical Officer & VP-Drug Development at Critical Therapeutics, Inc. He then worked as Chief Medical Officer & VP-Clinical Development at Ironwood Pharmaceuticals, Inc. from 2005 to 2016.
After that, he worked as Chief Medical Officer & Senior Vice President at Ra Pharmaceuticals, Inc. and as Principal at GSK Plc.
Johnston received his undergraduate degree from Davidson College and his doctorate from Duke University School of Medicine.
Former positions of Jeffrey M. Johnston
| Companies | Position | End |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2015 |
| RA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| GSK PLC | Corporate Officer/Principal | - |
Triangle Pharmaceuticals, Inc.
 Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Chief Tech/Sci/R&D Officer | - |
| Critical Therapeutics, Inc. | Chief Tech/Sci/R&D Officer | - |
Training of Jeffrey M. Johnston
| Davidson College | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 3 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey M. Johnston
